Log in

ASX:MMSMcMillan Shakespeare Stock Price, Forecast & News

A$7.46
-0.10 (-1.32 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$7.13
Now: A$7.46
A$7.57
50-Day Range
A$6.37
MA: A$7.20
A$7.56
52-Week Range
A$5.01
Now: A$7.46
A$16.97
Volume440,830 shs
Average Volume241,408 shs
Market Capitalization$577.26 million
P/E Ratio9.68
Dividend Yield11.25%
BetaN/A
McMillan Shakespeare Limited provides salary packaging, vehicle leasing administration, fleet management, and retail financial services in Australia, the United Kingdom, and New Zealand. The company operates in three segments: Group Remuneration Services, Asset Management, and Retail Financial Services. The Group Remuneration Services segment offers administrative services related to salary packaging; and facilitates the settlement of motor vehicle novated leases for customers. It also provides ancillary services associated with motor vehicle novated lease products. The Asset Management segment offers financing and ancillary management services associated with motor vehicles, commercial vehicles, and equipment. The Retail Financial services segment provides retail brokerage services, aggregation of finance originations, and extended warranty covers. The company is also involved in the software development business. It serves federal and state governments, health groups, not-for-profit organizations, and private corporations. McMillan Shakespeare Limited was founded in 1988 and is headquartered in Melbourne, Australia.
Read More
McMillan Shakespeare logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.00 out of 5 stars


Industry, Sector and Symbol

Industry Staffing & Outsourcing Services
Sub-IndustryN/A
SectorIndustrials
CUSIPN/A
CIKN/A
Phone+61-3-90973000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$547.01 million
Cash FlowA$0.66 per share
Book ValueA$3.86 per share

Profitability

Miscellaneous

Employees1,283
Market Cap$577.26 million
Next Earnings Date8/20/2020 (Estimated)
OptionableOptionable

Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for MMS and its competitors with MarketBeat's FREE daily newsletter.

McMillan Shakespeare (ASX:MMS) Frequently Asked Questions

How has McMillan Shakespeare's stock been impacted by COVID-19 (Coronavirus)?

McMillan Shakespeare's stock was trading at A$8.70 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MMS shares have decreased by 14.3% and is now trading at A$7.46. View which stocks have been most impacted by Coronavirus.

When is McMillan Shakespeare's next earnings date?

McMillan Shakespeare is scheduled to release its next quarterly earnings announcement on Thursday, August 20th 2020. View our earnings forecast for McMillan Shakespeare.

How were McMillan Shakespeare's earnings last quarter?

McMillan Shakespeare Limited (ASX:MMS) announced its quarterly earnings results on Wednesday, February, 20th. The company reported $0.42 earnings per share for the quarter. View McMillan Shakespeare's earnings history.

How often does McMillan Shakespeare pay dividends? What is the dividend yield for McMillan Shakespeare?

McMillan Shakespeare declared a Interim dividend on Thursday, February 20th. Stockholders of record on Friday, March 20th will be paid a dividend of 0.34 per share on Friday, March 20th. This represents a dividend yield of 2.85%. The ex-dividend date of this dividend is Thursday, March 5th. View McMillan Shakespeare's dividend history.

Has McMillan Shakespeare been receiving favorable news coverage?

News coverage about MMS stock has been trending very positive on Tuesday, InfoTrie reports. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. McMillan Shakespeare earned a daily sentiment score of 3.5 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutMcMillan Shakespeare.

Who are some of McMillan Shakespeare's key competitors?

What other stocks do shareholders of McMillan Shakespeare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McMillan Shakespeare investors own include Janus Henderson Group (HGG), Genesis Energy (GEL), Westpac Banking (WBC), UGL (UGL), Reject Shop (TRS), G8 Education (GEM), Eastern (EML) and Capitol Health (CAJ).

Who are McMillan Shakespeare's key executives?

McMillan Shakespeare's management team includes the following people:
  • Mr. Michael Neil Salisbury, MD, CEO & Director
  • Mr. Mark Blackburn CPA, DipBus(Acct), GAICD, CFO & Company Sec.
  • Mr. Geoff Kruyt, Managing Director of Maxxia UK
  • Mr. Simon Haidar, Group Exec. of Sales & Product Services
  • Ms. Tania Turnbull, Group Exec. of Marketing

What is McMillan Shakespeare's stock symbol?

McMillan Shakespeare trades on the ASX under the ticker symbol "MMS."

What is McMillan Shakespeare's stock price today?

One share of MMS stock can currently be purchased for approximately A$7.46.

How big of a company is McMillan Shakespeare?

McMillan Shakespeare has a market capitalization of $577.26 million and generates $547.01 million in revenue each year. McMillan Shakespeare employs 1,283 workers across the globe.

What is McMillan Shakespeare's official website?

The official website for McMillan Shakespeare is www.mcms.com.au.

How can I contact McMillan Shakespeare?

McMillan Shakespeare's mailing address is L 21 360 Elizabeth St, MELBOURNE, VIC 3000, Australia. The company can be reached via phone at +61-3-90973000.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.